Investing Ideas
/
New Zealand Pharmaceuticals & Biotech Potentially Undervalued Companies

New Zealand Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

1 companies

AFT Pharmaceuticals

Market Cap: NZ$291.5m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

AFT

NZ$2.78

6.1%

-12.0%